MENU
+Compare
OCGN
Stock ticker: NASDAQ
AS OF
Apr 2, 04:59 PM (EDT)
Price
$0.69
Change
+$0.04 (+6.15%)
Capitalization
201.2M

OCGN Ocugen Forecast, Technical & Fundamental Analysis

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe... Show more

OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for OCGN with price predictions
Apr 01, 2025

OCGN in upward trend: 10-day moving average broke above 50-day moving average on April 01, 2025

The 10-day moving average for OCGN crossed bullishly above the 50-day moving average on April 01, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on March 24, 2025. You may want to consider a long position or call options on OCGN as a result. In of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OCGN just turned positive on March 20, 2025. Looking at past instances where OCGN's MACD turned positive, the stock continued to rise in of 59 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where OCGN advanced for three days, in of 217 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for OCGN moved out of overbought territory on March 31, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

OCGN moved below its 50-day moving average on April 01, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OCGN broke above its upper Bollinger Band on March 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for OCGN entered a downward trend on March 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OCGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.789) is normal, around the industry mean (13.458). P/E Ratio (0.000) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (46.083) is also within normal values, averaging (251.391).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OCGN is expected to report earnings to rise 20.00% to -5 cents per share on May 02

Ocugen OCGN Stock Earnings Reports
Q1'25
Est.
$-0.06
Q4'24
Beat
by $0.01
Q3'24
Est.
$-0.06
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.02
The last earnings report on March 05 showed earnings per share of -5 cents, beating the estimate of -5 cents. With 3.58M shares outstanding, the current market capitalization sits at 201.20M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development and commercialization of therapies for eye diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11 Great Valley Parkway
Phone
+1 484 328-4701
Employees
84
Web
https://www.ocugen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARGYX8.78N/A
N/A
Invesco Global Real Estate Y
FGITX40.02N/A
N/A
Fidelity Advisor Growth & Income M
HRCIX54.17N/A
N/A
Carillon ClariVest Capital Apprec I
RGRLX10.29N/A
N/A
RBC Global Equity Leaders R6
JFNIX67.17-1.52
-2.21%
Janus Henderson Global Life Sciences I

OCGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with RAIN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCGN
1D Price
Change %
OCGN100%
-8.37%
RAIN - OCGN
53%
Loosely correlated
+2.45%
ARRY - OCGN
47%
Loosely correlated
-0.21%
AXON - OCGN
46%
Loosely correlated
+2.90%
BCRX - OCGN
40%
Loosely correlated
-3.33%
LRMR - OCGN
37%
Loosely correlated
-6.98%
More